ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: PB0845

    P2Y receptor antagonists and tyrosine kinase inhibitors reduce oxLDL-mediated procoagulant platelet activity

    T. Zheng1, T. Kohs1, J. Pang1, S. Reitsma1, I. Parra-Izquierdo1, A. Melrose1, M. Larson2, C. Williams1, M. Hinds1, O. McCarty3, J. Aslan1

  • Abstract Number: OC 41.4

    PACSIN2 regulates platelet integrin β1 hemostatic function

    R. Biswas1, N. Eaton1, M. Schulte1, M. Plomann2, K. Hoffmeister3, H. Falet1

  • Abstract Number: PB0675

    Pain as a Determinant of the Quality of Everyday Functioning of Persons with Haemophilia

    M. Marinić1, S. Rihtar2, A. Boban3

  • Abstract Number: PB1204

    Paradigm shift in ITP treatment patterns in the era of the COVID-19 pandemic – opportunity to study real world outcomes from an established platform: Update from UK Adult ITP registry.

    H. Miah1, A. Miah2, Q. Hill3, N. Cooper4, A. Newland1, D. Provan2, C. Bradbury5, M. Makris6, V. McDonald7

  • Abstract Number: PB0201

    Pathogenic variants in F8 gene – Results from the Brazilian Immune Tolerance (BrazIT) Study

    L. ZUCCHERATO1, R. Camelo2, L. Jardim3, M. Moreira Dias4, L. de Magalhães5, A. De Oliveira6, R. Ribeiro7, V. Franco8, M. Roberti9, F. Callado10, L. Etto11, M. De Cerqueira12, M. Cerqueira13, C. Lorenzato14, I. Pinto15, A. Garcia16, D. Neves17, D. Tan18, D. Chaves19, S. Rezende20

  • Abstract Number: OC 28.2

    Pathway-based Rare Variant Burden Analysis Identifies a Role for the Complement System in Purpura Fulminans

    P. Bendapudi1, S. Nazeen2, J. Ryu1, O. Soylemez2, B. Rouaisnel3, M. Colling4, B. Pasko1, A. Robbins3, M. Bouzinier2, L. Tomczak1, L. Collier1, S. Ram5, A. Toth-Petroczy2, E. Fieg2, W. Dzik4, J. Hudspeth6, O. Pozdnyakova7, R. Maas2, S. Sunyaev2, J. Losman3

  • Abstract Number: PB1318

    Patient characteristics associated with all-cause mortality of incident hospitalized pulmonary embolism patients: a nationwide cohort study

    Q. Chen, N. van Rein, S. Cannegieter

  • Abstract Number: PB0506

    Patient characteristics associated with arterial thromboembolism in incident hospitalized heart failure patients without other known indications for antithrombotic treatment: A nationwide cohort study

    Q. Chen1, N. van Rein1, M. Toorop2, W. Lijfering3, L. Tops1, S. Cannegieter1

  • Abstract Number: PB0461

    Patient outcomes of catheter directed thrombolysis for upper extremity deep vein thrombosis

    Y. Tan1, N. Thulasidasan2, S. Black2, K. Breen3

  • Abstract Number: PB0426

    Patients Reporting of Post-Traumatic Stress Disorder After Experiencing Venous Thromboembolic Event

    R. Rosovsky1, W. Robertson2, F. Klok3

  • Abstract Number: PB0427

    Patients Reporting on Relevant Functional Limitations Following an Episode of Venous Thromboembolism: The Post Venous Thromboembolism Functional Scale

    R. Rosovsky1, W. Robertson2, F. Klok3

  • Abstract Number: PB0780

    Patients with multiple myeloma have an increased prevalence of acquired platelet secretion defects and a disbalanced whole blood thrombin generation profile

    M. Roest1, Y. Sang2, L. Li3, J. Remijn4, R. Fijnheer5, R. Urbanus6, D. Huskens7, J. Wan2, B. de Laat8, J. Konings9

  • Abstract Number: OC 71.2

    PAUSE-2 Randomized Pilot Trial to Compare Two Strategies (PAUSE vs. ASRA) for Perioperative DOAC Management

    J. Douketis, J. Duncan, M. St John, P. Gross, S. Schulman

  • Abstract Number: PB0969

    PEBSI – Pulmonary Embolism Bleeding Score Index

    B. Dzudovic1, B. Subotic2, A. Neskovic3, J. Matijasevic4, S. Salinger5, J. Dzudovic6, S. Obradovic2

  • Abstract Number: PB0239

    Pediatric Primary Immune Thrombocytopenia: Observation in Armenia

    H. Grigoryan1, A. Avagyan2, C. Stepanyan3, S. Hovsepyan4, L. Vagarshakyan5, G. Tamamyan6, L. Hambardzumyan

  • Abstract Number: VPB0285

    Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm using Rivaroxaban

    N. Menon, N. Montanez

  • Abstract Number: PB0813

    Performance Evaluation of a VWF Antigen Assay in a Multicenter Study

    C. Gunnesch1, M. Boehm-Weigert1, R. Barten1, R. Biddle2, C. Eby3, R. Francis4, S. Pipe5, A. Siegemund6

  • Abstract Number: PB0565

    Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Apixaban on the Sysmex CN-3000/CN-6000 Systems

    D. Pahren, M. Wilkens, U. Groß, M. Merz, D. Bußfeld

  • Abstract Number: PB0556

    Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Rivaroxaban on the Sysmex CN-3000/CN-6000 Systems

    D. Pahren, M. Wilkens, U. Groß, M. Merz, D. Bußfeld

  • Abstract Number: PB1183

    Performance of a Chromogenic Factor IX Activity Assay in the Recovery of Factor IX Replacement Therapies

    T. Quinton1, J. Fraser2, K. Black2, A. Sadeghi-Khomami2

  • Abstract Number: OC 60.1

    Performance of clinical decision rules for venous thromboembolism in patients with a history of thrombosis

    V. Mai1, F. Klok2, M. Righini3, S. Schulman4, V. Thiruganasambandamoorthy5, S. Kahn6, V. Bates7, A. Pecarskie7, M. Kovacs8, S. Visser9, S. Shivakumar10, M. Tan11, E. Martens12, M. Rodger13, D. Scarvelis7, A. Delluc7, P. Girard14, M. Huisman15, P. Wells7, G. Le Gal7

  • Abstract Number: PB1177

    Performance of FVIII deficient plasma with VWF in the activity measurement of FVIII replacement products in plasma samples using an OSC assay.

    N. Kesavan1, M. Rahman1, A. Sadeghi-Khomami2, K. Black2, A. Wood3

  • Abstract Number: OC 31.1

    Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the Diagnostic Management of Pulmonary Embolism

    M. Stals1, J. Knijp2, L. Beenen3, M. Coppens4, L. Faber5, H. Hofstee6, M. Hovens7, M. Huisman8, T. van der Hulle9, K. Kaasjager10, M. Kruip11, A. Mairuhu12, S. Middeldorp13, M. Ten Wolde14, F. Klok1, N. van Es15

  • Abstract Number: PB0809

    Performance of the ISTH-BAT bleeding score in a population of newly diagnosed VWD in the U.S. Zimmerman Program

    P. Christopherson1, T. Abshire1, D. Doherty2, V. Flood3, S. Haberichter4, J. O'Donnell5, R. Montgomery4

  • Abstract Number: PB0920

    Performance of the Thrombogyn and Khorana scores for prediction of venous thromboembolism in ovarian cancer patients after major surgery

    N. Guman1, H. Wiegers2, M. Schaafsma3, F. Mulder1, S. Mom2, N. van Es2

  • Abstract Number: PB0464

    Peri-operative management of anticoagulation and bleeding in patients undergoing Catheter Directed Thrombolysis for acute iliofemoral Deep Vein Thrombosis

    K. White1, K. creeper2, S. Black3, N. Thulasidasan3, K. Breen4

  • Abstract Number: PB0480

    Periarticular Hemangioma as a Cause of Chronic Arthropathy due to Hemarthrosis

    Z. KARAKAS1, A. UNUVAR2, Y. Yilmaz3, D. Tugcu4, G. Tanyildiz4, S. KARAMAN1

  • Abstract Number: OC 02.4

    Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies

    A. Padmanabhan1, A. Kanack2, B. Singh1, G. George3, K. Gundabolu4, S. Koepsell4, Y. Abou-Ismail5, K. Moser5, K. Smock5, D. Green6, A. Major7, C. Chan7, G. Wool7, M. Reding8, A. Ashrani1, A. Bayas9, D. Grill1

  • Abstract Number: VPB0249

    Persistent autoantibodies against Factor XI in a girl with an inborn error of immunity

    E. Annetta1, M. Hepner2, J. Frontroth3, C. Cervio3, R. Sueldo4, V. Goris5, M. Oleastro6, G. Sciuccati7

  • Abstract Number: PB0588

    Persistent morphological alterations of endothelial colony-forming cells after 9 months in patients recovered from COVID-19

    D. CHAVARRIA-HERNANDEZ1, A. Figueroa-Torres2, V. MANUEL-DOMINGUEZ2, R. ARREOLA-DIAZ2, a. chave-gonzalez2, A. Majluf Cruz3, j. alvarado-Moreno2

  • Abstract Number: OC 67.2

    Personalized Assessment of the Protein C Pathway Using Endothelial Colony Forming Cells

    N. Schwarz1, J. Müller2, H. Yadegari3, J. Oldenburg4, B. Pötzsch3, H. Rühl3

  • Abstract Number: OC 62.2

    Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study

    B. Gunka1, D. Mackenzie2, A. Doumouras3, S. Mithoowani4

  • Abstract Number: OC 77.4

    Pharmacological targeting of GPV in a novel humanized mouse model to modulate thrombus formation in vivo

    P. Öftering1, S. Beck2, D. Stegner3, B. Nieswandt4

  • Abstract Number: PB1357

    Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study

    M. Donadini1, A. Squizzato2, P. Ferrazzi3, S. Maggioni4, C. Sacco3, C. Lodigiani5

  • Abstract Number: OC 73.2

    Phascolarctobacterium was increased in ITP and negatively correlated with platelet counts

    H. Wang, H. Bi, Z. Zeping

  • Abstract Number: PB0336

    Phenotypic and genetic features of thirteen families with variants in GP1BA, GP1BB and GP9 genes

    C. Monteiro1, M. Pereira2, M. Gonçalves3, A. Gonçalves4, C. Lau3, E. Cruz5, S. Morais6, R. Santos7

  • Abstract Number: PB1264

    Phenotypic heterogeneity within healthy donor endothelial colony forming cells explored by morphological analysis and RNA expression profiling

    S. Laan1, R. Dirven2, I. van Moort3, T. Kuipers4, H. Mei4, J. Eikenboom2, R. Bierings5, S. Boer6

  • Abstract Number: OC 39.1

    Phenotypic switch of platelet function from preterm to term neonates – daily life data from the Platelets In Neonatal Infants Study (PLINIUS)

    M. Drayss1, L. Weiss2, K. Mott2, C. Haertel3, C. Speer4, H. Schulze5, O. Andres6

  • Abstract Number: PB0363

    Phosphoinositide dynamics in megakaryocyte/platelet granule integrity and platelet functions

    S. Severin1, M. Caux2, R. Mansour2, J. Xuereb2, G. Chicanne2, J. Viaud2, A. Vauclard2, F. Boal2, B. Payrastre2, H. Tronchere2

  • Abstract Number: PB0466

    Physician practice behaviors surrounding dose-reduction of direct oral anticoagulants for the extended phase treatment of venous thromboembolism

    S. Woller1, D. Groat2, R. Rosovsky3, K. Sanfilippo4, L. Baumann Kreuziger5, M. Gaddh6, E. Eyster7, K. Martin8

  • Abstract Number: VPB1384

    Pilot Study of Effect on Thromboprophylaxis using System-wide Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized patients

    K. Zhen1, Q. Gao1, Z. Zhai2

  • Abstract Number: PB0392

    Pim kinase: A novel regulator of platelet and megakaryocyte thromboxane A2 and C-X-C-R motif receptors

    S. Nock1, L. Hutchinson2, K. Naseem3, S. Jones1, S. Mundell2, A. Unsworth4, M. blanco-Lopez1

  • Abstract Number: PB1039

    Plant heparinoids and their involvement in the regulation of blood coagulation

    E. Maystrenko1, M. Lyapina1, M. Kalugina1, S. Sorokoletov2

  • Abstract Number: OC 18.2

    Plasma exosomes reflect myocardial injury detected by Cardiac Magnetic Resonance in STEMI patients

    M. Zarà1, A. Baggiano2, C. Banfi3, J. Campodonico2, C. Tedesco4, P. Amadio3, S. Gili2, G. De Dona2, L. Sandrini3, G. Marenzi2, G. Pontone2, S. Barbieri3

  • Abstract Number: PB1339

    Plasma Levels of P-Selectin and Future Risk of Venous Thromboembolism

    S. Swamy1, S. Brækkan2, T. Ueland3, J. Hansen4, O. Snir5

  • Abstract Number: PB0258

    Plasma Lipoprotein(a) and Factor VIII levels after pediatric renal transplantation: a 10-year experience from a tertiary center in Brazil

    B. Blanco1, M. Garanito1, D. Celeste1, C. Ortega2, A. Watanabe2, V. Koch2, J. Carneiro1

  • Abstract Number: PB0935

    Plasma MiRNAs and the Risk of Venous Thromboembolism in Patients with Glioblastoma: A Nested Case-control Study

    J. Riedl1, M. Hackl2, A. Diendorfer2, M. Preusser3, G. Widhalm4, K. Roessler4, I. Pabinger5, C. Ay5, F. Erhart4

  • Abstract Number: OC 43.4

    Plasmin-cleaved VWF: a biomarker for microthrombosis

    H. El Otmani1, S. Smits1, N. van Kleef1, R. Frunt1, S. De Maat2, C. Maas2

  • Abstract Number: PB0626

    Plasminogen deficiency: a case series of an ultra-rare disease in a Spanish centre

    O. Benítez Hidalgo1, M. Huguet Mas2, A. de Jaureguizar Tesas2, M. Martínez García1

  • Abstract Number: PB0083

    Platelet activation and COVID-19 mortality: insights from coagulopathy, antiplatelet therapy and inflammation

    A. Philippe1, R. CHOCRON2, G. BONNET3, N. YATIM4, W. SUTTER5, J. HADJADJ6, O. WEIZMAN7, C. L. GUERIN8, T. Mirault9, C. SAMAMA10, B. Planquette11, B. TERRIER12, V. WALDMANN13, M. FONTENAY14, O. Sanchez15, J. DIEHL15, P. GAUSSEM16, A. COHEN17, N. Gendron18, D. Smadja19

  • Abstract Number: PB0769

    Platelet Activation and Expression of CAR on Cardiomyocytes and Platelets: Implication on Inflammation in Patients with Dilated Cardiomyopathy

    G. Elena1, L. Buryachkovsaya1, N. Mironova1, P. Chumachenko1, S. Golitsyn1, M. Othman2

  • Abstract Number: PB0862

    Platelet activation via glycoprotein VI initiates thrombin generation: a potential role for platelet-derived factor IX?

    L. Li1, M. Roest2, J. Meijers3, B. de Laat4, R. Urbanus5, P. de Groot6, D. Huskens7

  • Abstract Number: PB0752

    Platelet and immune cell cloaking of circulating tumour cells [CTCs] in breast and ovarian cancer

    M. Ward1, L. Kane2, S. Lochrin3, C. Ovaere4, C. O’Gorman4, R. O'Connor5, T. Kelly5, B. Mohamed5, M. Bates5, M. Carter5, J. Kennedy3, A. Tierney3, J. Beirne6, W. Kamran4, F. Abu Saadeh7, K. Cadoo8, L. Norris9, C. Martin10, S. O'Toole11, J. O'Leary12

  • Abstract Number: PB0753

    Platelet count as a novel diagnostic marker for early lung cancer diagnosis: an epidemiological study

    M. Barlow1, G. Pula2, W. Hamilton1, S. Bailey1

  • Abstract Number: PB1212

    Platelet desialylation status in adults with primary immune thrombocytopenia

    T. Schramm1, C. Ungerböck2, M. Fillitz3, B. Dixer3, D. Mehic4, T. Backchoul5, I. Marini6, J. Zlamal5, C. Ay7, I. Pabinger7, J. Gebhart1

  • Abstract Number: PB0855

    Platelet dysfunction in HFpEF patients: plasma and whole blood measurements

    G. D'Italia1, D. Coenen2, T. Lemmens3, S. Wielders3, A. Al-Abadi3, S. Toutouh3, J. Franssen4, S. Mourmans4, B. Tullemans3, J. Weerts4, A. Barandiaran Aizpurua4, V. van Empel4, B. Schroen4, J. Cosemans3

  • Abstract Number: PB1246

    Platelet Dysfunction in Inherited Thrombocytopenias with Predisposition to Hematologic Malignancies and its Correlation with Bleeding: Analysis of 23 Patients with RUNX1, ANKRD26, and EVT6 Mutations

    I. Tesakov1, D. Fedorova1, G. Ovsyannikova1, A. Martyanov2, A. Ignatova1, E. Ponomarenko1, A. Pavlova1, E. Raykina1, P. Zharkov1, N. Smetanina1, M. Panteleev2, A. Sveshnikova1

  • Abstract Number: OC 77.3

    Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability

    J. Mitchell1, G. Little2, A. Bye3, A. Unsworth4, R. Gaspar5, N. Kriek2, T. Sage2, A. Stainer5, D. Sangowawa5, N. Curry6, S. Shapiro6, M. Desborough6, C. Whyte7, J. Gibbins8, N. Mutch7, C. Jones8

  • Abstract Number: PB0887

    Platelet function in MS-NASH mice: a newly developed obesity model

    C. Peng1, S. Whiteheart2

  • Abstract Number: PB0876

    Platelet function testing and timing of bypass surgery – A platelet function sub-study from the RAPID CABG randomized trial

    M. Lordkipanidzé1, G. Wells2, M. Le May2, F. Rubens2, L. Chen2, M. Ruel2, A. Chong2, M. Welman1, L. Perrault3, V. Chan2, J. Tanguay3, D. So2

  • Abstract Number: PB0870

    Platelet functional phenomics in the post-acute stage of pulmonary embolism

    S. von Ungern-Sternberg1, V. ten Cate2, M. Nagler3, M. Panova-Noeva4, B. Dahlen5, J. Prochaska2, S. Heitmeier6, C. Gerdes7, S. Konstantinides8, T. Münzel9, C. Espinola-Klein10, K. Lackner11, H. Spronk12, H. ten Cate13, P. van der meijden14, K. Leineweber7, P. Wild2, K. Jurk15

  • Abstract Number: OC 75.3

    Platelet generation from circulating megakaryocytes is triggered in the lung vasculature

    X. Zhao1, D. Alibhai1, T. Walsh1, N. Tarassova1, S. Birol1, C. Williams1, C. Neal1, E. Aitken1, A. Waller2, J. Ballester-Beltran3, P. Gunning4, E. Hardeman5, E. Agbani6, I. Hers1, C. Ghevaert3, A. Poole1

  • Abstract Number: PB0380

    Platelet glycoprotein analysis by flow cytometry, could further diagnostic information be gained from the mean fluorescence intensity values?

    A. McCormick, O. Galvez, S. Nasim, M. Panetta, Y. Daniel

  • Abstract Number: PB0388

    Platelet glycoprotein Ibα carries ABO blood group antigens

    K. Tiemeyer1, M. Hollenhorst1, K. Aoki2, M. Ishihara2, C. Bertozzi3

  • Abstract Number: OC 72.1

    Platelet HMGB1 mediates pathological NET formation in Ischemic Stroke

    F. Denorme1, I. Portier1, Y. Kosaka1, J. Rustad1, M. Cody1, C. Yost1, M. Neal2, J. Majersik1, R. Campbell1

  • Abstract Number: PB0884

    Platelet hyperaggregability in Framingham Heart Study participants living with obesity

    B. Nkambule1, M. Chan2, A. Lachapelle2, F. Thibord3, J. Cunha4, R. Pashek5, M. Chen2, A. Johnson2

  • Abstract Number: VPB0897

    Platelet indices at the titanium rod implantation in rabbit femur

    E. Volokitina, I. Antropova, S. Kutepov, D. Chelchushev, M. Dobrinskaia

  • Abstract Number: PB0773

    Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation

    M. Villa-Fajardo1, M. Yáñez Palma2, A. Acebes-Huerta3, P. Martínez-Botía4, M. Meinders5, M. Nolte6, C. Benavente Cuesta7, J. Eble8, J. del Castillo2, F. Martín-Sánchez2, L. Gutiérrez9

  • Abstract Number: PB0513

    Platelet P2Y12 Receptor Polymorphism and Gene-Gene Interactions in Patients with High Cardiovascular Risk

    P. Shorikov, D. Shorikova, E. Shorikov, A. Esmaeil, O. Khukhlina

  • Abstract Number: VPB0106

    Platelet parameters in patients with COVID-19 and ST-elevation myocardial infarction

    N. Izmozherova, A. Popov, I. Antropova, A. Tsvetkov, L. Kadnikov, V. Ispavsky

  • Abstract Number: VPB0778

    Platelet proteomics reveals an inflammatory phenotype of platelets in type 2 diabetes

    Y. Kong1, R. Rehan2, J. Weaver3, C. Houlahan4, B. Johnston4, K. Peng4, M. Cielesh4, M. Larance5, F. Passam6

  • Abstract Number: OC 56.2

    Platelet RalA/B play pivotal roles in regulation of venous thrombosis by co-ordinating P-selectin-HMGB1 interaction

    Y. Li1, C. Williams2, B. Amulic2, A. Poole2

  • Abstract Number: PB0883

    Platelet reactivity and thrombogenicity in Framingham Heart Study participants with hypertriglyceridemia

    B. Nkambule1, M. Chan2, A. Lachapelle2, F. Thibord3, J. Cunha4, R. Pashek5, M. Chen2, A. Johnson2

  • Abstract Number: PB0852

    Platelet reactivity is associated with arterial tonometry, vessel diameters and calcium burden

    J. Cunha1, M. Chan2, B. Nkambule3, F. Thibord4, A. Lachapelle2, R. Pashek5, R. Vasan6, J. Rong7, E. Benjamin6, N. Hamburg6, M. Chen2, G. Mitchell8, A. Johnson2

  • Abstract Number: PB0587

    Platelet reactivity to SARS-CoV-2 Spike protein and domains.

    A. Cano-Méndez, M. Damían-Vázquez, N. García-Larragoiti, S. López-Castañeda, A. Ochoa-Zarzosa, M. Viveros-Sandoval

  • Abstract Number: OC 75.5

    Platelet release device: From bench-scale to large culture platelet production

    A. Pongerard1, L. Mallo1, V. Do Sacramento1, O. Boiron2, F. Lanza1, C. GACHET1, Y. KNAPP3, C. Strassel1

  • Abstract Number: PB1194

    Platelet Response to Avatrombopag Following Switch from Eltrombopag or Romiplostim in Primary vs. Secondary Immune Thrombocytopenia: A Multicenter Study of U.S. ITP Referral Centers

    H. Al-Samkari1, D. Jiang2, T. Gernsheimer2, H. Liebman3, S. Lee3, C. Bernheisel4, S. Kolodny4, M. Wojdyla4, M. Vredenburg4, A. Cuker5

  • Abstract Number: OC 64.2

    Platelet RNA sequencing and generation of an imMKCL-based cell model for SLFN14 K219N deficiency show evidence of increased cellular stress

    F. Ver Donck1, K. Ramaekers1, C. Thys1, K. Peerlinck2, C. Van Geet3, K. Eto4, V. Labarque3, K. Freson1

  • Abstract Number: PB0851

    Platelet secretion in wound healing: the essence of appropriate granule biogenesis

    D. Coenen1, S. Whiteheart2

  • Abstract Number: PB1227

    Platelet transfusion better preserves ROTEM clot strength and thrombin generation: a case-control study

    A. Rossetto1, P. Vulliamy2, L. Green3, R. Davenport4

  • Abstract Number: PB1259

    Platelet α-granule content induces endothelial damage and blood brain barrier breakdown in experimental stroke

    V. Göb1, L. Zimmermann2, K. Hemmen3, G. Stoll4, B. Nieswandt5, K. Heinze6, M. Schuhmann4, D. Stegner7

  • Abstract Number: OC 41.1

    Platelet αIIbβ3 integrin is produced in different covalent forms that have different functions

    A. Pijning1, M. Blyth2, M. Coote2, F. Passam3, J. Chiu4, P. Hogg4

  • Abstract Number: PB0190

    Platelet-dependent factor VIII activity is more susceptible to inhibitor antibodies than phospholipid vesicle-dependent factor VIII activity

    G. Gilbert1, V. Novakovic2, M. Chatterjee2

  • Abstract Number: VPB1298

    Platelet-derived miRNAs and platelet-derived extracellular vesicles as emerging diagnostic and prognostic biomarkers in acute ischemic stroke patients

    C. Eyileten1, D. Jakubik1, A. Shahzadi2, J. Jarosz-Popek1, D. Keshwani1, A. Gasecka1, M. Wolska3, A. Nowak1, S. De Rosa4, E. van der Pol5, D. Mirowska-Guzel1, I. Kurkowska-Jastrzebska6, A. Czlonkowska6

  • Abstract Number: PB0772

    Platelet-Leukocyte Aggregates as Markers of (Pro)Thrombotic Inflammation

    A. Peshkova1, K. Sounbuli2, Y. Selivanova2, I. Andrianova2, R. Litvinov3, J. Weisel4

  • Abstract Number: OC 66.2

    Platelet-mediated potentiation of the lung pre-metastatic niche in breast cancer

    H. Roweth1, M. Malloy2, Q. Guo3, I. Becker4, S. McAllister3, E. Battinelli3

  • Abstract Number: OC 49.4

    Platelet-released mitochondria interact with neutrophils, altering their phenotype and merging with the existing mitochondrial network

    H. Allan1, P. Ferreira2, M. Crescente3, P. Armstrong4, T. Warner4

  • Abstract Number: VPB1223

    Platelet-Specific CD8+ T Cells in Patients with Immune Thrombocytopenia

    J. Vrbensky1, I. Nazy1, J. Kelton1, M. Larché2, R. Clare1, H. Bhakta1, M. Roussakis1, V. Rybenchuk1, D. Arnold1

  • Abstract Number: VPB1425

    Platelets And Neutrophils Co-Drive Procoagulant Potential in Antiphospholipid Syndrome During Pregnancy

    E. Agbani1, E. Mahe2, S. Chaturvedi3, L. Yamaura4, P. Schneider4, M. Barber4, M. Choi4, A. Lee5, L. Skeith4

  • Abstract Number: VPB0900

    Platelets and von Willebrand factor after exposure to turbulent, but low shear flow with implications in mechanical circulatory support

    A. Liu, D. Bark

  • Abstract Number: PB0751

    Platelets are integral components of the tumor microenvironment whose regulatory actions vary with the tumor type

    O. Le Chapelain1, S. Jadoui2, V. Ollivier2, B. Ho-Tin-Noé3

  • Abstract Number: LB 02.4

    Platelets as Versatile Effectors of Thromboinflammation in Chronic Myeloproliferative Neoplasms

    A. Krishnan1, Z. Shen2

  • Abstract Number: PB0157

    Platelets genetically modified with mRNA-lipid nanoparticles are functionally similar to clinically transfused platelets in vitro

    C. Strong1, J. Leung2, K. Badior3, M. Robertson4, E. Jan4, P. Cullis4, D. Devine4, C. Kastrup5

  • Abstract Number: PB0771

    Platelets promote neutrophil extracellular traps mediated thrombo-inflammation and glomerular endothelial dysfunction in diabetic kidney disease

    A. Gupta1, K. Singh1, R. Younis1, S. Krishnan2, S. Fatima2, S. Ambreen2, H. Mai2, N. Hoffmann2, R. Biemann2, K. Shahzad2, S. Zimmermann2, B. Isermann3, S. Kohli3

  • Abstract Number: OC 32.2

    Pleiotropic influence of rosuvastatin on apolipoproteins and their association with coagulation factor levels: results from the START trial

    E. Camilleri1, N. van Rein1, B. van Vlijmen2, J. Biedermann3, M. Kruip4, F. Leebeek5, F. van der Meer6, C. Cobbaert7, S. Cannegieter1, W. Lijfering1

  • Abstract Number: PB0919

    Polygenic risk scores for prediction of cancer-associated venous thromboembolism: a UK Biobank analysis

    N. Guman1, F. Mulder1, B. Ferwerda2, A. Zwinderman2, H. Buller3, N. van Es2, P. Kamphuisen4

  • Abstract Number: PB0422

    Polymeric prosthetic heart valves with low thrombogenicity

    S. Melo1, A. Aqil2, B. Ditkowski3, C. Jérôme2, P. Lancellotti4, C. Oury3

  • Abstract Number: VPB1312

    Polymorphism of genes associated with fibrin clot structure or/and lysis rate could influence the risk of pulmonary embolism in young patients with venous thromboembolism

    A. Chechulova1, S. Kapustin2, Z. Sidorova2, J. Drijun2, V. Soldatenkov2, L. Papayan3, V. Soroka4, A. Tomchenko4

  • Abstract Number: PB1149

    Pooled analysis of long-term efficacy and safety of simoctocog alfa in previously treated patients with haemophilia A

    M. Mathias1, A. Borchiellini2, F. Peyvandi3, A. Chistolini4, R. Marino5, A. Rocino6, M. Sol Cruz7, S. Carolina Oliva8, A. Molina Pantoja9, C. Grimley10, S. Bayart11, A. Klukowska12, T. Lissitchkov13, S. Halimeh14, S. Werner15, G. Pezeshki15, S. Knaub16, C. Kessler17

  • Abstract Number: VPB0945

    Poor Performance Status and Elevated Factor VIII Levels Increase Thrombotic Risk in Lymphoma and Multiple Myeloma Patients

    I. Sánchez Prieto, I. Gutiérrez Jomarrón, C. Martínez Vázquez, J. García Suárez

  • Abstract Number: PB0894

    Population-based reference ranges of platelet function tests and their discriminative ability for cardiovascular disease

    S. von Ungern-Sternberg1, M. Panova-Noeva2, V. ten Cate3, B. Dahlen4, G. Buch5, S. Rapp6, J. Prochaska3, K. Strauch7, M. Beutel8, A. Schuster9, K. Lackner10, T. Münzel11, P. Wild3, K. Jurk12

  • Abstract Number: PB1213

    Possible targets to reduce fatigue in chronic immune thrombocytopenia patients – an explorative study

    W. van Dijk1, M. Nap-van der vlist2, H. Knoop3, R. Schutgens4

  • Abstract Number: PB0424

    Post thrombotic syndrome: quality of life and incidence in patients under treatment with direct oral anticoagulants.

    A. Poretto1, L. Spiezia2, A. Codognola3, E. Campello4, D. Tormene3, F. Dalla Valle3, P. Simioni5

  • Abstract Number: PB1181

    Post-Menopausal Bleeding and Arterial Thrombosis in Biological Females with Inherited Bleeding Disorders

    G. Moyer1, M. Manco-Johnson2

  • Abstract Number: PB1182

    Post-Operative Bleeding and Thrombosis in Biological Females with Inherited Bleeding Disorders: A Cross-Sectional Analysis from the Community Counts Registry

    G. Moyer1, M. Manco-Johnson2

  • Abstract Number: PB0007

    Post-partum Acquired Haemophilia A in the COVID era – building the case for Emicizumab?

    C. Crossette-Thambiah1, D. Arachchillage2, M. Laffan3

  • Abstract Number: OC 52.3

    Post-Partum Hemorrhage in Sub-Saharan Africa – First Results from a Prospective Study in Mozambique

    M. Glenzer1, R. Barnes1, M. Correia2, E. Luis2, I. Boaventura2, V. Nhantumbo2, N. Manguele2, P. Silva2, A. von Drygalski3

  • Abstract Number: PO0043

    Post-thrombotic hypercoagulation syndrome in patients with hemoblastoses

    I. Berger

  • Abstract Number: PB0428

    Post-thrombotic syndrome in patients with venous thromboembolism treated with rivaroxaban – Results from the FIRST Registry

    V. Speed1, L. Roberts2, J. Patel1, R. Patel1, R. Arya1

  • Abstract Number: VPB1416

    Postpartum Thromboprophylaxis Following Caesarean Delivery

    M. Bastrash, C. Antinora, M. Plourde, M. Trahan, C. Simard, M. Koolian, E. Suarthana, K. wou, I. Malhamé

  • Abstract Number: PB0966

    Potential utility of a multi-component coagulation factor panel to detect portal vein thrombosis and assess hemostasis in chronic liver disease

    C. Lewis1, K. Bari2, C. Xie3, K. Sherman2, M. Vasse4, P. Van Dreden5, V. Bogdanov6

  • Abstract Number: PB0397

    PPAR-alpha inhibition of platelet activation and thrombosis

    L. Stanger1, A. Yamaguchi1, R. Adili2, M. Holinstat3

  • Abstract Number: PB1134

    Practical utilisation of Octapharma FVIII concentrates in previously untreated and minimally treated haemophilia A patients entering routine clinical treatment – The Protect-NOW Study

    S. Halimeh1, J. Oldenburg2, R. Klamroth3, M. Mathias4, G. Hall5, P. Marco Vera6, M. Jansen7

  • Abstract Number: PB1178

    Praxbind for reversal of Dabigatran: experience in a tertiary hospital

    A. Lubetsky1, S. Lalezari2, G. Kenet3, M. Misgav2

  • Abstract Number: PB1067

    Pre-analytical screening and removal of Argatroban interference for Haemostasis assays

    S. Cox-Morton, D. White, M. Sharp, E. Duff, M. Kirk, C. Moore, M. Robinson, E. Symington, M. Besser, W. Thomas, S. MacDonald

  • Abstract Number: VPB1373

    Pre-Operative Thromboprophylaxis Does Not Cause Increased Bleeding Events in Patients with Surgically-Treated Hip Fractures

    H. Krzyzaniak, D. You, L. Skeith, P. Schneider

  • Abstract Number: PB0936

    Pre-surgical ovarian vein thrombosis in women with ovarian malignancies as predictor of pulmonary embolism

    H. Wiegers1, L. Beenen2, M. Schaafsma3, S. Middeldorp4, B. Hutten5, S. Mom6, L. Scheres7

  • Abstract Number: PO0059

    Prechemotherapy D-Dimer Levels as Predictors of Response Treatment in Colorectal Cancer

    E. Sundarita1, M. Syahrir2, Y. Andayani2, L. Legiran2, N. Djamaludin2

  • Abstract Number: PB1114

    Precision of One-Stage Clotting Factor Assays is Improved by Using Fresh Rather Than Stored Calibration Curves

    N. Yartey1, C. Dale1, M. Dave1, K. Lee2, S. Platton3

  • Abstract Number: PB1005

    Preclinical safety and toxicokinetics of VMX-C001 – an intravenous bypassing agent for factor Xa inhibitors

    D. Verhoef1, T. Gomes2, G. Short3, P. Reitsma1

  • Abstract Number: PB1432

    Predicting DVT Incidence based on risk factors by using Artificial Neural Networks

    Y. Yang1, Z. Zhongbin1, Y. Guo2

  • Abstract Number: PB1353

    Predicting post-discharge venous thromboembolism and major bleeding among medical patients: External validation of a risk score derived from readily available laboratory tests.

    S. Hyder1, G. Barnes2, H. Han1, S. Ash2, S. Woller3, B. Horne4, S. Stevens5

  • Abstract Number: OC 65.1

    Prediction of apixaban or rivaroxaban concentrations based on low molecular weight heparin anti-Xa activity using nomograms: a useful tool in emergency clinical situations like thrombolysis in stroke

    C. BRAKTA1, A. STEPANIAN2, R. ELAYEB3, M. NEUWIRTH4, E. CURIS5, M. DELRUE6, V. SIGURET1

  • Abstract Number: PB0502

    Prediction of bleeding risk in patients with cancer receiving anticoagulants

    E. Trinks-Roerdink1, G. Geersing1, F. Rutten1, S. van Doorn2

  • Abstract Number: PO0009

    Prediction of reccurent thrombotic events in survivors after COVID-19

    T. Pertseva1, L. Konopkina2, K. Bielosludtseva3, N. Habshydze2

  • Abstract Number: VPB0116

    Prediction of severe covid, proposition of a severe index

    I. Ghachem1, M. ZOUAOUY2, M. KAABAR3, A. Bachali4

  • Abstract Number: PB0959

    Predictive factors for thrombophilia diagnosis: a single-center cross sectional study

    K. Vrotniakaite-Bajerciene1, F. Schmidli2, K. Jalowiec2, H. Broughton2, J. Schneider2, A. Haynes3, J. Brodard2, A. Rovo2, J. Kremer Hovinga4, A. Angelillo-Scherrer2

  • Abstract Number: PB1320

    Predictive factors of clot propagation towards deep venous thrombosis and/or pulmonary embolism in superficial venous thrombosis patients: a systematic review

    F. van Royen1, M. van Smeden2, S. van Doorn3, F. Rutten2, G. Geersing2

  • Abstract Number: OC 27.5

    Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B (OPTI-CLOT TARGET study) – Preliminary results

    T. Goedhart1, L. Bukkems2, M. Coppens3, K. Fijnvandraat4, S. Schols5, R. Schutgens6, J. Eikenboom7, F. Heubel-Moenen8, P. Ypma9, L. Nieuwenhuizen10, K. Meijer11, F. Leebeek12, R. Mathôt13, M. Cnossen14

  • Abstract Number: OC 08.4

    Predictive risk factors for recurrent VTE in children

    S. Laabar1, K. Fijnvandraat2, E. Rettenbacher3, S. Gouw4, I. Klaassen5

  • Abstract Number: VPB0139

    Predictive value of D-dimer in Covid-19

    N. Vorobyeva1, A. Vorobyeva2

  • Abstract Number: PB0049

    Predictive value of Wells and Geneva score in suspected pulmonary thromboembolism in critically ill patients with COVID 19: A Retrospective Study

    N. Diaconu, T. Cuzor

  • Abstract Number: VPB0205

    Predictors of body mass index in persons with hemophilia over the life course: multisite, cross-sectional study (n=691)

    M. Glenzer1, R. Barnes1, A. von Drygalski2

  • Abstract Number: PB0267

    Predictors of Catheter-related Arterial Thrombosis in Pediatric Patients After Cardiac Catheterization

    R. Natesirinilkul1, S. Sethasathien2, N. Lawtrakulngam2, S. Silvilairat2, S. Manowong3, P. Tuntivate3

  • Abstract Number: OC 39.2

    Predictors of Platelet Function Disorders in Pediatric Patients

    B. Doshi1, E. Thompson2, A. Obstfeld3, M. Lambert1

  • Abstract Number: PB1315

    Predictors of Pregnancy Associated Venous Thromboembolism: A Case-Control Study

    M. AlSheef1, a. abu-shaheen1, A. Zia Zaidi2, O. Alarfaj3

  • Abstract Number: PB0072

    Predictors of venous thromboembolism in hospitalised COVID-19 positive patients

    P. MacCallum1, S. Virdone1, S. Williams2, T. Bariana2, K. Pieper1, U. Maheshwari1, A. Kakkar1

  • Abstract Number: PB0793

    Preference for ravulizumab over eculizumab: a real-world patient preference and life impact study on the treatment of atypical hemolytic uremic syndrome

    T. Mauch1, M. Chladek2, S. Cataland3, S. Chaturvedi4, B. Dixon5, K. Garlo6, C. Gasteyger6, A. Java7, J. Leguizamo8, L. Lloyd-Price9, T. Pham10, T. Symonds9, I. Tomazos6, Y. Wang6

  • Abstract Number: PB1395

    Pregnancy as a protective factor for bleeding in immune thrombocytopenia regardless of platelet count

    F. Chuliber1, A. Muñoz2, L. Llera2, V. Privitera3, D. Mezzarobba2, M. Villagra Iturre2, E. Viñuales2, J. Arbelbide2, D. Penchasky2

  • Abstract Number: PB0706

    Pregnancy in women with Factor XI deficiency ( < 60 UI/dL) and use of neuraxial analgesia : real life data in a French cohort of 314 pregnancies

    C. Flaujac1, C. Cavalie2, N. Drillaud3, C. Lavenu-Bombled4, S. Timsit5, P. Billoir6, C. Desconclois7, L. Touzet8, A. Lebreton9, I. Diaz-Cau10, R. d'Oiron11, M. Giansily-Blaizot10, M. Fretigny12, S. Desage13, B. Wibaut14, P. Beurrier15, F. Volot16, L. Rugeri17, V. Roussel-Robert18, E. de Raucourt19

  • Abstract Number: PB1408

    Pregnancy-induced change in platelet transcription, metabolism, and aggregation: a longitudinal study from pre-pregnancy to postpartum

    E. Montenont1, H. Campbell1, J. Rowley2, N. Tolley1, A. Blair1, C. Stubben1, J. Cox1, R. Souvenir3, D. Abel4, A. Weyrich5, M. Rondina1, R. Campbell1

  • Abstract Number: PB0885

    Pregnancy-specific glycoprotein 9 potentiates platelet function mediated by immunoreceptor tyrosine-based activation motif pathways

    I. Parra-Izquierdo1, A. Melrose1, J. Pang1, J. Lo1, M. Hinds1, A. Maloyan1, G. Dveskler2, O. McCarty3, J. Aslan1

  • Abstract Number: PB0781

    Prelatent and Native Antithrombin Effect on Cell Cycle and Proliferation of Glioblastoma Multiforme Cells

    J. Peñas-Martínez1, D. Zaragoza Huesca2, E. Navarro Mazano3, E. Cuenca Zamora3, S. Espín4, V. Vicente5, A. Carmona Bayonas6, I. Martínez Martínez7

  • Abstract Number: OC 47.2

    Prevalence and characteristics of non-neutralizing FVIII-specific antibodies in persons with hemophilia A – preliminary results

    I. Oomen1, M. Miranda2, P. Allacher3, E. Beckers4, M. Coppens5, M. Driessens6, J. Eikenboom7, K. Fijnvandraat1, S. Hassan8, L. Hooimeijer9, P. Kaijen2, F. Leebeek10, F. Rosendaal11, S. Schols12, H. Schweiger13, C. Smit14, L. van Vulpen15, J. van der Bom11, J. Voorberg2, S. Gouw16

  • Abstract Number: VPB0737

    Prevalence and Impact of Antiphospholipid Antibodies on Thrombotic Events in Ambulatory Cancer Patients

    C. Kansuttiviwat1, P. Niprapan2, L. Norasetthada2, E. Rattaritamrong2, A. Tantiworawit2, P. Piriyakhuntorn2, S. Hantrakool3, N. Hantrakun2, T. Punnachet2, C. Chai-Adisaksopha2

  • Abstract Number: OC 06.5

    Prevalence and Severity of Bleeding Events in Thrombotic Antiphospholipid Syndrome – Should They be Included in the Damage Index for Antiphospholipid Syndrome?

    P. Gaspar1, F. Farinha2, Z. Sayar3, M. Efthymiou4, H. Cohen5, D. Isenberg6

  • Abstract Number: PB0102

    Prevalence of cerebrovascular MRI markers in hospitalized patients with COVID-19

    N. Wijers1, T. van Lith2, W. Sluis3, F. Meijer4, K. Kamphuis-van Ulzen5, J. de Bresser6, J. Dankbaar7, F. Klok8, A. Tuladhar9, S. Cannegieter10, M. Wermer11, B. van der Worp3, M. Huisman12, F. de Leeuw9

  • Abstract Number: PB0421

    Prevalence of Guideline Discordant Aspirin use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement

    B. Haymart1, X. Kong1, G. Barnes1, J. Errickson1, E. Kline-Rogers2, M. Ali3, V. Shah4, J. Froehlich2, S. Kaatz4

  • Abstract Number: VPB0203

    Prevalence of inhibitors in haemophilia patients: a study of 92 patients at the Annaba University Hospital Center in Algeria

    H. BROUK, A. AMIRECHE

  • Abstract Number: PB0248

    Prevalence of iron deficiency anemia in children with hemophilia

    S. Zarb1, M. Bhatt2, K. Decker3, J. Ewusie4, A. Chan4

  • Abstract Number: PB0195

    Prevalence of Sporadic Haemophilia A: an updated analysis of two cohort studies

    S. Rezende1, D. Chaves2, L. Jardim3, R. Camelo4, L. ZUCCHERATO5, M. Santana5

  • Abstract Number: PB1335

    Prevalence of venous thromboembolism and its associations with demographics, disease spectrum and hydroxyurea use in a large racially homogenous population of sickle cell disease patients in Nigeria

    H. Okoye1, C. Ezekekwu2, T. Nwagha3, K. Korubo4, H. Omunakwe5, O. Nnachi6, A. Madu2, B. Nwogoh7, C. Efobi8, E. Muoghalu9, C. Nonyelu10, A. Okoye6, O. Obodo11, C. Ugwu9, M. Egolum12, o. nnachi6, I. Okpala2

  • Abstract Number: PB0924

    Prevalence, treatment and prognosis of tumor thrombi in renal cell carcinoma

    F. Kaptein1, T. van der Hulle1, S. Braken1, E. van Gennep1, J. Buijs1, M. Burgmans1, S. Cannegieter1, E. Du Chatinier1, M. Huisman2, E. van Persijn van Meerten1, H. Versteeg1, R. Pelger1, F. Klok3

  • Abstract Number: OC 15.1

    PREVAPIX-ALL: Phase 3 Study of the Safety and Efficacy of Apixaban for Thromboprophylaxis versus Standard of Care in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia or Lymphoma (ALL/LL)

    S. O'Brien1, V. Rodriguez2, G. Lew3, J. Newburger4, C. Schultz5, E. Orgel6, K. Derr7, M. Ranalli8, A. Esbenshade9, J. Hochberg10, H. Kang11, Y. Dinikina12, C. Crevar13, M. Donovan13, J. Dyme13, N. Favatella13, L. Mitchell14

  • Abstract Number: OC 38.4

    Preventing CD62P-mediated leukocyte infiltration and activation enhances thrombus resolution in mice

    J. Kral-Pointner1, P. Haider2, P. Szabo3, C. Kaun2, M. Brekalo2, M. Salzmann1, K. Schneider3, S. Bleichart4, A. Kiss3, C. Hengstenberg5, C. Brostjan4, H. Bergmeister3, A. Assinger1, B. Podesser3, J. Wojta1, P. Hohensinner3

  • Abstract Number: PO0033

    Prevention of perioperative hemorrhage during open cardiac surgery in children with high titer inhibitor by Emicizumab combined with rhFVII:one case report

    X. Feng1, S. Zheng2, J. Sun3, Z. Wang4, H. Li5, Z. Chen6, q. Li7, J. Lai8, J. Du5

  • Abstract Number: VPB0033

    Prevention of stroke and other thromboembolic events in primary care: alarming data from a Brazilian medium-size city

    M. Marcolino1, J. Oliveira1, D. Rios2, T. PEDROSO3, L. Sá4, M. Parreiras Martins5, T. Sales2, A. Ribeiro1

  • Abstract Number: PB0551

    Prevention of tumor cell-induced coagulation activation by the small-molecule FXIa inhibitor, BMS-262084, is dependent on tissue factor (TF) expression levels

    J. Mäder1, M. Voigtländer2, C. Rolling2, A. Schulenkorf2, C. Lehr2, C. Bokemeyer2, L. Beckmann3, F. Langer2

  • Abstract Number: PB0265

    Prevention of Upper Extremity PICC-associated Thrombosis Using Squeeze Balls in the Inpatient Oncology Setting: Preliminary Findings from a Prospective Single-Arm Non-Randomized Investigation

    E. Harris1, J. Finkelstein2, B. Esty2, O. Halyabar2, C. Cherella2, C. Parsons1, R. Rosen3, D. Morhardt4, B. Aiyanyor1, D. O'Meara1, S. Ferrell2, D. Ciccolini2, E. Lambrinos2, E. Drake5, K. Humphrey2, R. Kumar6

  • Abstract Number: PB1359

    Prevention of VTE in Hospitalized Patients with Acute Infectious Disease: Online CME Improves Physician Competence and Confidence

    M. Harris1, C. Padbury2, M. LaCouture3

  • Abstract Number: PB0025

    Primary hemostasis, coagulation and fibrinolysis markers in patients with intracranial large vessel occlusion stroke, on admission to hospital

    A. Barakzie1, A. Bruggeman2, G. Dirks3, D. Dippel4, M. Charles2, M. de Maat5

  • Abstract Number: OC 26.1

    Procoagulant Platelet – Neutrophil Interactions Exacerbate Ischemic Stroke

    F. Denorme1, I. Portier1, Y. Kosaka1, A. Ajanel1, M. Cody1, B. Kile2, M. Rondina1, J. Majersik1, R. Campbell1

  • Abstract Number: OC 49.1

    Procoagulant platelets have a distinct transcriptome that identifies the large GTPase dynamin as a driver in their formation

    I. Tohidi-Esfahani1, S. Whittaker2, C. Lee2, H. Campbell2, K. Lai3, H. Liang2, M. Kockx2, M. Larance4, V. CHEN5

  • Abstract Number: VPB0583

    Procoagulant Properties of Titanium and Titanium Nitride

    M. Litvak1, A. Shamanaev2, A. Matafonov1, A. Kobrin3, E. Tucker4, M. Wallisch4, O. McCarty5, D. Gailani3

  • Abstract Number: VPB0524

    Procoagulatory Changes in Patients with Chronic Lower Limb Ischemia

    K. Komissarov1, V. Soldatenkov2, L. Papayan3, S. Bessmeltsev1, N. Silina1, S. Kapustin2, V. Burakov1, N. Saltykova1, O. Kuzakbirdieva1, O. Matvienko4, O. Soldatenkova1

  • Abstract Number: PB0186

    Production of a Bispecific Monoclonal Antibody that Enhances Canine FIXa activation of Canine FX

    D. Monroe1, J. Chang2, M. Caughey3, E. Merricks4, T. Nichols5

  • Abstract Number: PB0354

    Production of platelets in vitro in functionalised 3-dimensional scaffolds mimicking the bone marrow niche

    H. Foster1, M. Colzani1, G. Bouet Chalon1, D. Howard1, C. Di Buduo2, N. Muller-Sienerth3, A. Waller1, Y. Sun4, J. Shepherd5, A. Evans1, P. Soprano6, M. Parsons7, Y. Ying Sims8, E. Turro9, P. Maguire10, S. Best5, R. Cameron5, A. Balduini11, G. Wright3, C. Ghevaert12

  • Abstract Number: OC 60.4

    Prognostic Model for Predicting the Risk of Symptomatic Venous Thromboembolism in Children and Adolescents with Lymphoma

    D. Evstratov1, N. Myakova1, P. Zharkov2

  • Abstract Number: PB0585

    Prognostic value of troponin elevation at admission and during monitoring in COVID-19 patients

    A. BEAUVAIS1, N. Gendron2, A. Philippe3, B. VEDIE1, M. LORIOT1, P. JUVIN1, O. Sanchez4, J. DIEHL4, D. Smadja5, R. CHOCRON6

  • Abstract Number: VPB1343

    Prolonged Hypercoagulability Occurs Following Pelvic and Acetabular Fractures, as Defined by Serial Thrombelastography

    A. Clarke, L. Skeith, R. Korley, A. Dodd, P. Duffy, R. Martin, P. Schneider

  • Abstract Number: VPB1380

    Prolonged Platelet-mediated Hypercoagulability Occurs Following Surgically Treated Hip Fractures

    P. Schneider, A. Dodd, P. Duffy, R. Martin, R. Korley, L. Skeith

  • Abstract Number: VPB1382

    Prolonged Post-operative Hypercoagulability Can be Defined Using Serial Thrombelastography in Patients with Metastatic Bone Disease

    L. Yamaura, L. Skeith, M. Monument, P. Schneider

  • Abstract Number: PB0169

    Proof of principle of a fast and fully automated FVIII functional inhibitor test

    B. Verbruggen1, N. Binder2, G. Moore3, R. Polenewen4

  • Abstract Number: VPB0329

    Propensity Matched Comparison of Incidence and Outcomes of Heparin-Induce Thrombocytopenia in Patients Undergoing Percutaneous Cardiac Intervention vs Coronary Artery Bypass Grafting

    K. Park1, P. Aung2

  • Abstract Number: VPB0118

    Proper algorithm in donor-recipient selection, the key to success in convalescent plasma treatment of Covid 19 patients

    A. Grdinic1, D. Vojvodic2

  • Abstract Number: PB0703

    Prophylaxis with human coagulation factor X in an adolescent girl with hereditary major Stuart factor deficiency.

    F. ZEKRE1, F. TARDY2, A. BIGUET PETIT JEAN3, S. THOUVENIN3, C. LEGENDRE3, P. NOYEL3, P. DE MAZANCOURT4, B. TARDY3, C. Berger5

  • Abstract Number: PB0716

    Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency During Surgery or Childbirth

    C. Solomon1, M. Jansen2, S. Knaub3, C. Kessler4

  • Abstract Number: OC 19.5

    Protease-Nexin-1,a serpin participating in neutrophil recruitment through CD11a integrin regulation.

    C. Madjene1, L. Venisse2, K. Aymonier3, Y. Boulaftali3, V. Arocas3, M. Bouton3

  • Abstract Number: OC 28.4

    Protective Role of Plasminogen Deficiency in Non-Alcoholic Fatty Liver Disease and Glucose Dysmetabolism

    W. Hur, Y. Nguyen, K. King, Y. Patel, M. Flick

  • Abstract Number: OC 55.4

    Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor by post-translational modification of functional arginine residues.

    S. Thomassen1, B. Bouwens1, K. Wichapong1, D. Suylen1, F. Bouwman2, T. Hackeng1, R. Koenen3

  • Abstract Number: VPB1421

    Protein C and Antithrombin III of Pregnant Women Visiting Antenatal Clinic in University of Calabar Teaching Hospital, Calabar, Nigeria

    D. Okpokam1, A. Okoli1, E. Akwiwu1, J. Akpotuzor1, A. Udo2

  • Abstract Number: VPB0162

    Protein Expression in Plasma after Hemarthrosis Differs Among Recombinant FVIII and FVIII-Fc Fusion Replacement in FVIII-Deficient Mice

    J. Zhou1, B. Chumappumkal Joseph2, C. Gonzalez3, D. Gonzalez3, T. Whisenant4, A. von Drygalski1

  • Abstract Number: PB0165

    Protein S Gla detects and attenuates early vascular calcification

    A. Gentier1, S. Agten2, L. Schurgers3, T. Hackeng3

  • Abstract Number: OC 38.1

    Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury

    R. Gogiraju1, S. Gachkar2, D. Velmeden2, M. Bochenek3, K. Zifkos4, A. Hubert2, T. Münzel5, S. Offermanns6, K. Schäfer4

  • Abstract Number: OC 35.3

    Protein tyrosine phosphatase PTPN22 modulates platelet function and thrombosis

    J. Qiao, X. Wang, G. Wei, L. Zeng, K. Xu

  • Abstract Number: OC 05.2

    Proteome and phosphoproteome analyses of SARS-CoV-2-infected humanized K18-ACE2 mice reveal hyperactive phenotype of circulating platelets

    S. Subramaniam1, R. Matthew Hekman2, A. Jayaraman3, A. Kateri O'Connell4, M. Paige Montanaro5, D. Kenney6, M. Ericsson7, S. Walachowski3, B. Blum2, K. Ravid8, N. A Crossland9, F. Douam9, A. Emili2, M. Bosmann10

  • Abstract Number: PB0756

    Proteomic and functional profile of platelet-derived extracellular vesicles released under physiological and tumour-associated conditions

    M. Vismara1, M. Manfredi2, M. Zarà3, L. Galgano4, S. Trivigno4, A. Piotti5, I. Canobbio1, M. Torti5, G. Guidetti1

  • Abstract Number: PB0368

    Proteomics demonstrate differences in protein lifespan regulation in platelets from adult and pediatric donors

    A. Garzon Dasgupta1, A. Ignatova2, V. Zgoda3, A. Martyanov4, A. Sveshnikova2

  • Abstract Number: VPB0736

    Prothrombin can modulate its expression in colon cancer cells

    M. Cumbo1, S. Dunjic Manevski2, B. Tomic2, M. Gvozdenov2, V. Djordjevic2

  • Abstract Number: OC 55.5

    Prothrombin Circulates in Human Plasma in Multiple Covalent Forms with Differing Activities

    M. Schreuder, D. Butera, J. Chiu, P. Hogg

  • Abstract Number: PB1094

    Prothrombinase-induced clotting time for the measurement of rivaroxaban, apixaban, and edoxaban drug concentrations: a cross-sectional study

    V. Sathanantham1, J. Studt2, A. Mendez3, L. Alberio4, P. Fontana5, W. Wuillemin6, A. Schmidt7, L. Graf8, B. Gerber9, G. Mäder10, C. Bovet10, T. Sauter10, M. Nagler11

  • Abstract Number: PB1397

    Psychological and cognitive factors involved in decision-making process of haemophilia carriers in reproductive choices

    I. Cutica1, M. Mortarino2, I. Garagiola3, G. Pravettoni4, F. Peyvandi5

  • Abstract Number: PB1211

    Psychological support for patients with Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) in Germany

    L. Schönborn1, M. Braune-Krickau2, L. Stiefel2, A. Greinacher3, H. Grabe2

  • Abstract Number: VPB0469

    Pulmonary cement embolism after kyphoplasty: Clinical and Laboratory aspects of pro-coagulant effects

    V. Muster1, P. Jud2, K. Gütl2, F. prüller2, L. Schweiger2, T. Gary2, M. Brodmann2, R. raggam2

  • Abstract Number: PB0967

    Pulmonary hemodynamics at rest and during exercise in patients with chronic thromboembolic pulmonary disease

    A. Dhayyat1, J. Hilde2, Ø. Jervan3, K. Stavem4, W. Ghanima5, K. Steine6

  • Abstract Number: PB1294

    Pulmonary thrombosis promotes sever flu in mice exposed to cigarette smoke.

    T. Kaminski, T. Brzoska, K. Robinson, T. Nyunoya, P. Sundd

Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley